1
|
Weymouth-Wilson AC: The role of
carbohydrates in biologically active natural products. Nat Prod
Rep. 14:99–110. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Seeberger PH and Werz DB: Automated
synthesis of oligosaccharides as a basis for drug discovery. Nat
Rev Drug Discov. 4:751–763. 2005. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Gui M, Shi DK, Huang M, Zhao Y, Sun QM,
Zhang J, Chen Q, Feng JM, Liu CH, Li M, et al: D11, a novel
glycosylated diphyllin derivative, exhibits potent anticancer
activity by targeting topoisomerase IIα. Invest New Drugs.
29:800–810. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Shi DK, Zhang W, Ding N, Li M and Li YX:
Design, synthesis and biological evaluation of novel glycosylated
diphyllin derivatives as topoisomerase II inhibitors. Eur J Med
Chem. 47:424–431. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pradheepkumar CP, Panneerselvam N and
Shanmugam G: Cleistanthin A causes DNA strand breaks and induces
apoptosis in cultured cells. Mutat Res. 464:185–193. 2000.
View Article : Google Scholar : PubMed/NCBI
|
6
|
You Y: Podophyllotoxin derivatives:
Current synthetic approaches for new anticancer agents. Curr Pharm
Des. 11:1695–1717. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Meenakshi J, Shanmugam G and Cleistanthin
A: a diphyllin glycoside from Cleistanthus collinus, is
cytotoxic to PHA-stimulted (proliferating) human lymphocytes. Drug
Dev Res. 51:187–190. 2000. View Article : Google Scholar
|
8
|
Hemmati S, Schneider B, Schmidt TJ,
Federolf K, Alfermann AW and Fuss E: Justicidin B 7-hydroxylase, a
cytochrome P450 monooxygenase from cell cultures of Linum perenne
Himmelszelt involved in the biosynthesis of diphyllin.
Phytochemistry. 68:2736–2743. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang ZT, Ma J, Zhu L and Zhao Y:
Synthesis and identification of cytotoxic diphyllin glycosides as
vacuolar H(+)-ATPase inhibitors. Euro J Med Chem. 82:466–471. 2014.
View Article : Google Scholar
|
10
|
Zhao Y, Ni C, Zhang Y and Zhu L: Synthesis
and bioevaluation of diphyllin glycosides as novel anticancer
agents. Arch. Pharm (Weinheim). 345:622–628. 2012. View Article : Google Scholar
|
11
|
Tuchinda P, Kumkao A, Pohmakotr M,
Sophasan S, Santisuk T and Reutrakul V: Cytotoxic arylnaphthalide
lignan glycoside from the aerial parts of Phyllanthus
taxodiifolius. Plant Med. 72:60–62. 2006. View Article : Google Scholar
|
12
|
Chen C, Wang CC, Wang Z, Geng WY, Xu H,
Song XM and Luo DQ: Cytotoxic activity of a synthetic
deoxypodophyllotoxin derivative with an opened D-ring. J Asian Nat
Prod Res. 18:486–494. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kandil S, Wymant JM, Kariuki BM, Jones AT,
McGuigan C and Westwell AD: Novel cis-selective and
non-epimerisable C3 hydroxy azapodophyllotoxins targeting
microtubules in cancer cells. Eur J Med Chem. 3:311–325. 2016.
View Article : Google Scholar
|
14
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
15
|
Jaing JD, Davis AS, Middleton K, Ling YH,
Perez-Soler R, Holland JF and Bekesi JG:
3-(Iodoacetamido)-benzoylurea: A novel cancericidal tubulin ligand
that inhibits microtubule polymerization, phosphorylates bcl-2 and
induces apoptosis in tumor cells. Cancer Res. 58:5389–5395.
1998.PubMed/NCBI
|
16
|
Davis AS, Jiang JD, Middleton KM, Wang Y,
Weisz I, Ling YH and Bekesi JG: Novel suicide ligands of tubulin
arrest cancer cells in S-phase. Neoplasia. 1:498–507. 1999.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Hyman AA, Middleton K, Centola M,
Mitchison TJ and Carbon J: Microtubule-motor activity of a yeast
centromere-binding protein complex. Nature. 359:533–536. 1992.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Shin JW, Son JY, Kang JK, Han SH, Cho CK
and Son CG: Trichosanthes kirilowii tuber extract induces G2/M
phase arrest via inhibition of tubulin polymerization in HepG2
cells. J Ethnopharmacol. 115:209–216. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen FH, Zhang LB, Qiang L, Yang Z, Wu T,
Zou MJ, Tao L, You QD, Li ZY, Yang Y and Guo QL: Reactive oxygen
species-mitochondria pathway involved in LYG-202-induced apoptosis
in human hepatocellular carcinoma HepG(2) cells. Cancer Lett.
296:96–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Solier S and Pommier Y: MDC1 cleavage by
caspase-3: A novel mechanism for inactivating the DNA damage
response during apoptosis. Cancer Res. 71:906–913. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hande KR, Hagey A, Berlin J, Cai Y, Meek
K, Kobayashi H, Lockhart AC, Medina D, Sosman J, Gordon GB and
Rothenberg ML: The pharmacokinetics and safety of ABT-751, a novel,
orally bioavailable sulfonamide antimitotic agent: Results of a
phase 1 study. Clin Cancer Res. 12:2834–2840. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou
JP, Lee SJ, Chang YL, Chen LT, Chen CT and Chang JY: BPR0L075, a
novel synthetic indole compound with antimitotic activity in human
cancer cells, exerts effective antitumoral activity in vivo. Cancer
Res. 64:4621–4628. 2004. View Article : Google Scholar : PubMed/NCBI
|
23
|
Benaka Prasad SB, Vinaya K, Ananda Kumar
CS, Swarup S and Rangappa KS: Synthesis of novel
6-fluoro-3-(4-piperidinyl)- 1,2-benzisoxazole derivatives as
antiproliferative agents: A structure-activity relationship study.
Invest New Drugs. 27:534–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kroemer G, Dallaporta B and Resche-Rigon
M: The mitochondrial death/life regulator in apoptosis and
necrosis. Annu Rev Physiol. 60:619–642. 1998. View Article : Google Scholar : PubMed/NCBI
|